glp 1 injection frequency Weight Loss Injections — MesoHealth GLP-1 Injection Frequency for Weight
Description
Liraglutide, the molecule in Victoza, was approved by the FDA for type 2 diabetes in 2010
In studies, people lost around 11 to 13% of their body weight
However, some employers have found that suppliers have withdrawn, or have threatened to withdraw, drug manufacturer rebates, meaning the per-unit cost of coverage would increase dramatically
Maloney A, Rosenstock J, Fonseca V
Keep in mind that individual outcomes with Semaglutide can differ based on factors like initial weight and lifestyle choices
